Government Affairs
Refine Search
Pharmaceutical
As part of its latest budget announcement, Australia's federal government has allocated A$2.2 billion ($2.37 billion) funding for mental health, under a five-year reform package. These reforms are aimed at improving the lives of thousands of Australians with mental illness by: 11 May 2011
Pharmaceutical
A bipartisan bill, S 733, designed to address a Medicare reimbursement flaw and seeking to reverse cancer care payment shortfalls has been introduced in the USA by Senator Pat Roberts (Republican, Kansas) and lead co-sponsor Senator Debbie Stabenow (Democrat, Michigan). 9 May 2011
Pharmaceutical
Australia's federal government is ignoring its own growth forecasts for the Pharmaceutical Benefits Scheme (PBS), and making policy decisions without an evidence base, trade group Medicines Australia chief executive Brendan Shaw told industry experts in Sydney yesterday. 6 May 2011
Generics
To further reduce the cost of anti-malaria drug and reduce malaria incidence to the barest minimum, the Nigerian ministry of health says it has plans to produce them in the country. While briefing the press on the 2011 World Malaria Day on Tuesday in Abuja, Onyebuchi Chukwu, the Minister of Health said pharmaceutical industries in Nigeria are not producing the drugs because they are not certified by the World Health Organization to do so. 6 May 2011
Pharmaceutical
Australia's Federal Health Minister, Nicola Roxon has refused to back down from the government's decision to defer the Pharmaceutical Benefits Scheme (PBS) listing of critical drugs. 3 May 2011
Biotechnology
There is a need for a European Union industrial policy for the biosimilar medicines industry, says the European Generic Medicines Association (EGA). 'The EGA will therefore continue to be at the forefront of the biosimilars debate working with EU and global policy makers,' said Didier Barret, EGA president, in his opening address to the 9th EGA International Symposium on Biosimilar Medicines in London yesterday. The EGA president welcomed the EU biosimilars framework, which is operational and delivering, and also reminded the audience that biosimilar medicines have been safely in use for five years. 15 April 2011
Pharmaceutical
US President Barack Obama yesterday called on Congress to accept $4,000 billion in government spending cuts, unveiling his alternative to Republicans' deficit-cutting plans, offered a mix of $3 in spending cuts for every $1 in tax increases over the next 12 years. 14 April 2011
Pharmaceutical
Following the introduction of National Health Insurance (NHI) in 1995, the Israeli government's role in the pharmaceutical sector significantly increased. The first few years saw the establishment of a NHI basket of services with a process for updating, a greater involvement in co-payment policy (leading to a 50% increase in prescription copayments in 1998), changes to the Patent Law and data exclusivity regulations, as well as a number of pricing reforms, according to a report written by Dr Philip Sax, editor of the Israeli PHARMA Drug Bulletin. 12 April 2011
Generics
As free trade agreement talks between Europe and India resume in Brussels yesterday, the international medical humanitarian organization Medecins Sans Frontieres (MSF) said it is deeply concerned about new measures Europe is pushing to restrict the production of affordable generic medicines that MSF and others rely on to treat patients across the developing world. 8 April 2011
Pharmaceutical
PharmaPraxis, part of Brazilian drugmaker Axis Biotec, has announced the formalization of an agreement with Brazil's Ministry of Health to manufacture biologic drugs. 8 April 2011
Biotechnology
Results have been released from the annual CEO Biotechnology Industry Position Survey, this year conducted by Australian biotech trade group AusBiotech and Grant Thornton. This asked the industry's chief executives for their views on the operating environment, financing and public policy. 6 April 2011
Biotechnology
Commenting on the introduction of the America Invents Act, HR 1249, in the US House of Representatives, USA-based Biotechnology Industry Organization (BIO) president and chief executive Jim Greenwood said: 'BIO praises House Judiciary Committee Chairman Lamar Smith (Republican, Texas) for his introduction of a comprehensive patent reform bill similar to the bill adopted by the US Senate earlier this month by a nearly unanimous vote' (The Pharma Letter March 10). 4 April 2011
Biotechnology
Yesterday's budget announcements by Chancellor of the Exchequer George Osborne essentially bought few major surprises, since most changes had already been covered by the media. However, there was confirmation of the Patent Box reduced tax rate for UK inventions, along with a proposal for the life sciences sector, where he said, 'we will radically reduce the time it takes to get approval for the clinical trials.' 24 March 2011
Generics
Because of Russia's Pharma 2020 program regulations, designed to support local production, an increasing number of pharmaceutical companies are deciding to open their production facilities in the country. The total amount invested by pharmaceutical manufacturers in Russia could reach at least 1 billion euros ($1.4 billion), according to estimates included in the latest report from PMR, a Poland-based research and consulting company, entitled Generic and innovative drugs market in Russia and Ukraine 2011. 24 March 2011
Generics
All eyes are on the European Union (EU)-India trade agreement, and the repercussions it will have on access to medicines in India and for the developing countries that rely on Indian produced generic medicines, says consumer group Health Action International (HAI) International. 23 March 2011
Generics
India's Union Ministry Health has established a taskforce to address issues facing the country's pharmaceutical industry and evolve a long-term strategy for the sector, reports the local Business Standard newspaper, particularly with respect to the takeover of domestic drugmakers by multinational companies. Measures to tackle the problem of spurious drugs will also be a focus of the taskforce. 17 March 2011
Pharmaceutical
In its response to the UK government's consultation on value based pricing (VBP) of medicines, which was launched last December and closes tomorrow, the Association of the British Pharmaceutical Industry (ABPI) highlighted that the key issue to consider is how to ensure the value from new medicines reaches patients and the NHS. 16 March 2011
Generics
Senate Health, Education, Labor and Pensions Committee Chairman Tom Harkin (D-Iowa), along with Senators Jay Rockefeller (Democrat, West Virginia), Charles Schumer (Dem, New York), Debbie Stabenow (Dem, Michigan) and Sherrod Brown (Dem, Ohio) sent a letter to Food and Drug Administration Commissioner Margaret Hamburg urging the Food and Drug Administration to help ensure Americans have access to affordable generic drugs as soon as possible by making timely regulatory decisions. 16 March 2011
Generics
The proposed free trade agreement between the European Union and India has caused considerable debate and objections for the latter's drugmakers as well as AIDS activists and non-governmental organizations, with the likes of Medecins Sans Frontieres (MSF) mounting a campaign under the banner 'Europe ' Hands off our Medicines' and marches (The Pharma Letters passim). 15 March 2011
Generics
In a recent report to US Vice President Joe Biden and the US Congress, the Counterfeit Pharmaceutical Inter-Agency Working Group, that was set up last year by the Obama Administration, has recognized that the government cannot wait for a full-blown crisis before taking action on the growing counterfeit medicine threat. 14 March 2011
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze